TrialWiener klinische Wochenschrift2009

Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.

Josip Bago et al.PubMed ↗Publisher ↗

No numbers read from the abstract.